Skip to content

Clorox CLX Ratios & Valuation

FY'25FY'24FY'23FY'22
Profitability
Gross margin45.2%+2.3pp43%+3.6pp39.4%+3.5pp35.8%-7.8pp
Net margin11.4%+7.5pp3.9%+1.9pp2%-4.5pp6.5%-3.2pp
EBITDA margin19.5%+9.3pp10.2%+2.6pp7.6%-5.6pp13.2%-3.3pp
Free cash flow margin10.7%+3.9pp6.8%-5.8pp12.6%+5.1pp7.5%-5.3pp
Returns
Return on equity249.6%+147pp102.2%+63.8pp38.4%-57.2pp95.6%-12.1pp
Return on assets14.3%+9.5pp4.8%+2.3pp2.5%-4.9pp7.4%-3.9pp
Return on invested capital29.1%+16.9pp12.2%+4.9pp7.3%-9.6pp17%-7.8pp
Efficiency
Asset turnover1.3×0.0×1.2×0.0×1.2×+0.1×1.1×0.0×
Inventory turnover14.8×-2,008×2,022.5×+742×1,280.3×+1,268×12.1×+5.2×
Liquidity
Current ratio0.8×-0.2×+0.1×0.0×+0.1×
Quick ratio0.6×-0.5×+0.1×0.0×+0.4×
Cash ratio0.1×0.0×0.1×-0.1×0.2×+0.1×0.1×-0.1×
Leverage
Debt-to-equity9.1×+0.1×-4.5×13.4×+8.2×5.2×-2.6×
Debt-to-assets0.5×0.0×0.5×0.0×0.5×0.0×0.5×0.0×
Net debt / EBITDA-1.8×3.8×-0.8×4.6×+1.7×2.9×+0.5×
Interest coverage13.3×+7.8×5.4×+1.8×3.6×-3.1×6.7×-3.4×
Per Share
Book value per share$2.58-1.7%$2.63+48.3%$1.77-60.5%$4.49+39.0%
Valuation
Market capitalization$15.04B-11.3%$16.95B-13.8%$19.66B+13.3%$17.35B-21.5%
Enterprise value$17.79B-9.6%$19.68B-11.5%$22.25B+11.0%$20.05B-19.7%
Price / earnings18.6×-42.0×60.5×-71.4×132×+94.4×37.6×+6.4×
Price / sales2.1×-0.3×2.4×-0.3×2.7×+0.2×2.4×-0.6×
Price / book46.9×-4.8×51.7×-37.7×89.4×+58.2×31.2×-22.6×
EV / EBITDA12.8×-14.4×27.2×-12.2×39.4×+18.0×21.4×+0.8×
EV / sales2.5×-0.3×2.8×-0.2×+0.2×2.8×-0.6×
Free cash flow yield5.1%+2.2pp2.8%-1.9pp4.7%+1.6pp3.1%-1.2pp
Earnings yield5.4%+3.7pp1.7%+0.9pp0.8%-1.9pp2.7%-0.5pp
Dividend yield4%+0.5pp3.5%+0.5pp3%-0.3pp3.3%+0.8pp
PEG ratio0.1×-0.6×0.7×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Where do Clorox's ratios come from?
Every ratio is computed from Clorox's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.